Cargando…
Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
Abnormal angiogenesis is critical for portal hypertension in cirrhosis. Except for etiological treatment, no efficient medication or regime has been explored to treat the early stage of cirrhosis when angiogenesis is initiated or overwhelming. In this study, we explored an anti-angiogenesis effort t...
Autores principales: | Gao, Jin-Hang, Wen, Shi-Lei, Feng, Shi, Yang, Wen-Juan, Lu, Yao-Yao, Tong, Huan, Liu, Rui, Tang, Shi-Hang, Huang, Zhi-Yin, Tang, Ying-Mei, Yang, Jin-Hui, Xie, Hui-Qi, Tang, Cheng-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026725/ https://www.ncbi.nlm.nih.gov/pubmed/27380212 http://dx.doi.org/10.1007/s10456-016-9522-9 |
Ejemplares similares
-
Correction: Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2022) -
Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis
por: Gao, Jin-Hang, et al.
Publicado: (2013) -
Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisation
por: TONG, HUAN, et al.
Publicado: (2013) -
Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats
por: Su, Wei, et al.
Publicado: (2020) -
Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress
por: Tai, Yang, et al.
Publicado: (2021)